Deutsche Bank’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.27M | Sell |
566,781
-8,750
| -2% | -$65.9K | ﹤0.01% | 1301 |
|
|
2025
Q1 | $4.36M | Sell |
575,531
-4,605
| -0.8% | -$34.9K | ﹤0.01% | 1307 |
|
|
2024
Q4 | $7.07M | Buy |
580,136
+19,263
| +3% | +$235K | ﹤0.01% | 1161 |
|
|
2024
Q3 | $9.39M | Buy |
560,873
+5,806
| +1% | +$97.2K | ﹤0.01% | 1026 |
|
|
2024
Q2 | $9.68M | Buy |
555,067
+5,791
| +1% | +$101K | ﹤0.01% | 1011 |
|
|
2024
Q1 | $9.36M | Buy |
549,276
+3,692
| +0.7% | +$62.9K | ﹤0.01% | 1038 |
|
|
2023
Q4 | $5.56M | Buy |
545,584
+540,967
| +11,717% | +$5.51M | ﹤0.01% | 1203 |
|
|
2023
Q3 | $41.8K | Sell |
4,617
-3,676
| -44% | -$33.3K | ﹤0.01% | 3406 |
|
|
2023
Q2 | $89.2K | Sell |
8,293
-7,670
| -48% | -$82.5K | ﹤0.01% | 3314 |
|
|
2023
Q1 | $163K | Buy |
15,963
+3,654
| +30% | +$37.4K | ﹤0.01% | 3096 |
|
|
2022
Q4 | $130K | Buy |
12,309
+204
| +2% | +$2.15K | ﹤0.01% | 3190 |
|
|
2022
Q3 | $155K | Sell |
12,105
-1,993
| -14% | -$25.5K | ﹤0.01% | 3068 |
|
|
2022
Q2 | $181K | Sell |
14,098
-264
| -2% | -$3.39K | ﹤0.01% | 3213 |
|
|
2022
Q1 | $150K | Sell |
14,362
-1,662
| -10% | -$17.4K | ﹤0.01% | 3384 |
|
|
2021
Q4 | $247K | Buy |
16,024
+822
| +5% | +$12.7K | ﹤0.01% | 3246 |
|
|
2021
Q3 | $343K | Buy |
15,202
+6,882
| +83% | +$155K | ﹤0.01% | 3249 |
|
|
2021
Q2 | $214K | Sell |
8,320
-262
| -3% | -$6.74K | ﹤0.01% | 3709 |
|
|
2021
Q1 | $358K | Buy |
+8,582
| New | +$358K | ﹤0.01% | 3294 |
|